<?xml version='1.0' encoding='utf-8'?>
<document id="21996064"><sentence text="Histone deacetylase 1 is required for Carbamazepine-induced CYP3A4 expression."><entity charOffset="38-51" id="DDI-PubMed.21996064.s1.e0" text="Carbamazepine" /></sentence><sentence text="Carbamazepine (CBZ) is a commonly prescribed antiepileptic drug"><entity charOffset="0-13" id="DDI-PubMed.21996064.s2.e0" text="Carbamazepine" /><entity charOffset="15-18" id="DDI-PubMed.21996064.s2.e1" text="CBZ" /><pair ddi="false" e1="DDI-PubMed.21996064.s2.e0" e2="DDI-PubMed.21996064.s2.e0" /><pair ddi="false" e1="DDI-PubMed.21996064.s2.e0" e2="DDI-PubMed.21996064.s2.e1" /></sentence><sentence text=" Adverse effects and drug-drug interaction are the two major concerns for its clinic application" /><sentence text=" CBZ is mainly metabolized by cytochrome P450 (CYP) 3A4, a strong inducer of CYP3A4 as well, which in turn influences the pharmaceutical profiles of the co-administrated drugs"><entity charOffset="1-3" id="DDI-PubMed.21996064.s4.e0" text="CBZ" /></sentence><sentence text=" To date, little is known about the mechanisms underlying CBZ-induced CYP3A4 expression"><entity charOffset="58-60" id="DDI-PubMed.21996064.s5.e0" text="CBZ" /></sentence><sentence text=" In this study, we explored the possible roles of Pregnane X receptor (PXR) and the histone deacetylase 1 (HDAC1) on the CBZ-induced CYP3A4 expression"><entity charOffset="50-58" id="DDI-PubMed.21996064.s6.e0" text="Pregnane" /><entity charOffset="121-128" id="DDI-PubMed.21996064.s6.e1" text="CBZ" /><pair ddi="false" e1="DDI-PubMed.21996064.s6.e0" e2="DDI-PubMed.21996064.s6.e0" /><pair ddi="false" e1="DDI-PubMed.21996064.s6.e0" e2="DDI-PubMed.21996064.s6.e1" /></sentence><sentence text=" The results showed that: (1) Although the expression of PXR was increased in CBZ treated cells, PXR gene silencing surprisingly showed no significant effects on CBZ-induced CYP3A4 expression; (2) CBZ inhibited the binding of HDAC1 to the promoter of CYP3A4"><entity charOffset="78-80" id="DDI-PubMed.21996064.s7.e0" text="CBZ" /><entity charOffset="162-164" id="DDI-PubMed.21996064.s7.e1" text="CBZ" /><entity charOffset="197-199" id="DDI-PubMed.21996064.s7.e2" text="CBZ" /><pair ddi="false" e1="DDI-PubMed.21996064.s7.e0" e2="DDI-PubMed.21996064.s7.e0" /><pair ddi="false" e1="DDI-PubMed.21996064.s7.e0" e2="DDI-PubMed.21996064.s7.e1" /><pair ddi="false" e1="DDI-PubMed.21996064.s7.e0" e2="DDI-PubMed.21996064.s7.e2" /><pair ddi="false" e1="DDI-PubMed.21996064.s7.e1" e2="DDI-PubMed.21996064.s7.e1" /><pair ddi="false" e1="DDI-PubMed.21996064.s7.e1" e2="DDI-PubMed.21996064.s7.e2" /></sentence><sentence text=" In addition, both dominant negative form and siRNA of HDAC1 could repress the CBZ-induced CYP3A4 expression"><entity charOffset="79-81" id="DDI-PubMed.21996064.s8.e0" text="CBZ" /></sentence><sentence text=" These data, for the first time indicate that HDAC1, is required for the CBZ-induced CYP3A4 expression"><entity charOffset="73-75" id="DDI-PubMed.21996064.s9.e0" text="CBZ" /></sentence><sentence text="" /></document>